학술논문
Xeomin® , a Commercial Formulation of Botulinum Neurotoxin Type A, Promotes Regeneration in a Preclinical Model of Spinal Cord Injury
Document Type
Article
Source
In: Toxins . (Toxins, April 2023, 15(4))
Subject
Language
English
ISSN
20726651